On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...

The patent describes an extremely innovative and precise method for identifying rare genetic variants within biological ...

Mayo Clinic's Precision Mouse Engineering Core in Minnesota produces CRISPR/Cas9-mediated knockout and point mutant mice for researchers.

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...

YolTech's gene therapy is intended as a one-time life-long cure for patients living with PH1, which can lead to kidney ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

SNIPR BIOME ApS (“SNIPR” or “the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent EP4392563B on February 24th 2025 by the European Patent ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...